Pàgina inicial > Resultats de la cerca: Van der Poel, Marjolein
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
10 p, 523.7 KB Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide / Im, Annie (University of Pittsburgh/UPMC Hillman Cancer Center) ; Rashidi, Armin (University of Minnesota) ; Wang, Tao (Medical College of Wisconsin) ; Hemmer, Michael (Medical College of Wisconsin) ; MacMillan, Margaret L. (University of Minnesota) ; Pidala, Joseph (H. Lee Moffitt Cancer Center and Research Institute) ; Jagasia, Madan (Vanderbilt University Medical Center) ; Pavletic, Steven (National Cancer Institute of Bethesda) ; Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ; Weisdorf, Daniel (University of Minnesota) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Agrawal, Vaibhav (Indiana University School of Medicine) ; Al-Homsi, A.Samer (New York University Langone Medical Center) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Askar, Medhat (Baylor University Medical Center) ; Auletta, Jeffery J (Nationwide Children's Hospital) ; Bashey, Asad (Blood and Marrow Transplant Program at Northside Hospital) ; Beitinjaneh, Amer (University of Miami) ; Bhatt, Vijaya Raj (University of Nebraska Medical Center) ; Byrne, Michael (Vanderbilt University Medical Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes) ; Cairo, Mitchell S (New York Medical College) ; Castillo, Paul (UF Health Shands Children's Hospital) ; Cerny, Jan (University of Massachusetts Medical Center) ; Chhabra, Saurabh (Medical College of Wisconsin) ; Choe, Hannah (The Ohio State University Wexner Medical Center) ; Ciurea, Stefan (The University of Texas MD Anderson Cancer Center) ; Daly, Andrew (Tom Baker Cancer Center) ; Perez, Miguel Angel Diaz (Hospital Infantil Universitario Nino Jesus) ; Farhadfar, Nosha (University of Florida College of Medicine) ; Gadalla, Shahinaz M. (NIH-NCI Clinical Genetics Branch) ; Gale, Robert (Imperial College London) ; Ganguly, Siddhartha (University of Kansas Health System) ; Gergis, Usama (Thomas Jefferson University) ; Hanna, Rabi (Cleveland Clinic Foundation) ; Hematti, Peiman (University of Wisconsin) ; Herzig, Roger (University of Kentucky Chandler Medical Center) ; Hildebrandt, Gerhard C. (University of Kentucky) ; Lad, Deepesh P. (Postgraduate Institute of Medical Education and Research) ; Lee, Catherine (University of Utah) ; Lehmann, Leslie (Dana-Farber Cancer Institute/Boston Children's Hospital) ; Lekakis, Lazaros (University of Miami) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Kharfan-Dabaja, Momamed A. (Mayo Clinic) ; Khandelwal, Pooja (University of Cincinnati) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Murthy, Hemant S. (Mayo Clinic (Jacksonville, Estats Units d'Amèrica)) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; O'Brien, Tracey A. (Sydney Children's Hospital) ; Olsson, Richard F. (Uppsala University) ; Patel, Sagar S. (University of Utah) ; Perales, Miguel-Angel (Memorial Sloan Kettering Cancer Center) ; Prestidge, Tim (Starship Children's Hospital (Auckland, Nova Zelanda)) ; Qayed, Muna (Emory University School of Medicine) ; Romee, Rizwan (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Schoemans, Hélène (University Hospitals Leuven (Bèlgica)) ; Seo, Sachiko (Dokkyo Medical University) ; Sharma, Akshay (St. Jude Children's Research Hospital (Memphis, Estats Units d'Amèrica)) ; Solh, Melhem (Northside Hospital) ; Strair, Roger (Rutgers University) ; Teshima, Takanori (Hokkaido University Hospital) ; Urbano-Ispizua, Alvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Van der Poel, Marjolein (Maastricht University Medical Center) ; Vij, Ravi (Washington University School of Medicine) ; Wagner, John L. (Thomas Jefferson University) ; William, Basem (The Ohio State University) ; Wirk, Baldeep (Penn State Cancer Institute) ; Yared, Jean A. (University of Maryland) ; Spellman, Steve R. (Medical College of Wisconsin) ; Arora, Mukta (University of Minnesota Medical Center) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Universitat Autònoma de Barcelona
Post-transplant cyclophosphamide (PTCy) has significantly increased the successful use of haploidentical donors with a relatively low incidence of graft-versus-host disease (GVHD). Given its increasing use, we sought to determine risk factors for GVHD after haploidentical hematopoietic cell transplantation (haplo-HCT) using PTCy. [...]
2020 - 10.1016/j.bbmt.2020.05.001
Biology of blood and marrow transplantation, Vol. 26 Núm. 8 (august 2020) , p. 1459-1468  
Registre complet - Creative Commons
2.
12 p, 600.5 KB A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma / Carlo-Stella, Carmelo (Humanitas Research Hospital (Itàlia)) ; Zinzani, Pier Luigi (IRCCS Azienda Ospedaliero-Universitaria di Bologna) ; Sureda, Anna (Hospital Universitari de Bellvitge) ; Araújo, Luis (Universitário de Coimbra) ; Casasnovas, Olivier (CHU Dijon Bourgogne) ; Carpio Segura, Cecilia del Carmen (Hospital Universitari Vall d'Hebron) ; Yeh, Su-Peng (China Medical University Hospital) ; Bouabdallah, Krimo (University Hospital of Bordeaux) ; Cartron, Guillaume (Centre Hospitalier Universitaire Montpellier) ; Kim, Won Seog (Samsung Medical Center) ; Cordoba, Raul (Hospital Universitario Fundación Jiménez Díaz) ; Koh, Youngil (Seoul National University Hospital) ; Re, Alessandro (ASST Spedali Civili Brescia) ; Alves, Daniela (Centro Hospitalar Universitário Lisboa Norte) ; Chamuleau, Martine (Vrije Universiteit Amsterdam) ; Le Gouill, Steven (Institut Curie) ; López Guillermo, Armando (Hospital Clínic i Provincial de Barcelona) ; Moreira, Ilídia (Portuguese Institute of Oncology of Porto) ; van der Poel, Marjolein W. M. (Maastricht University Medical Center) ; Abbadessa, Giovanni (Sanofi) ; Meng, Robin (Sanofi) ; Ji, Ran (Sanofi) ; Lépine, Lucie (Sanofi) ; Saleem, Rao (Sanofi) ; Ribrag, Vincent (Institut Gustave Roussy (Villejuif, França)) ; Universitat Autònoma de Barcelona
Patients with relapsed or refractory lymphoma have limited treatment options, requiring newer regimens. In this Phase 1/2 study (NCT03769181), we assessed the safety, efficacy, and pharmacokinetics of isatuximab (Isa, anti-CD38 antibody) in combination with cemiplimab (Cemi, anti-programmed death-1 [PD-1] receptor antibody; Isa + Cemi) in patients with classic Hodgkin lymphoma (cHL), diffuse large B-cell lymphoma (DLBCL), and peripheral T-cell lymphoma (PTCL). [...]
2022 - 10.1002/hon.3089
Hematological Oncology, Vol. 41 (october 2022) , p. 108-119  
Registre complet - Creative Commons

Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem